|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | |
| A61K 39/395 | |||
| A61P 35/00 |
| (11) | Number of the document | 2797957 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12852317.2 |
| Date of filing the European patent application | 2012-11-20 | |
| (97) | Date of publication of the European application | 2014-11-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-06-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/066038 |
| Date | 2012-11-20 |
| (87) | Number | WO 2013/078191 |
| Date | 2013-05-30 |
| (30) | Number | Date | Country code |
| 201161563092 P | 2011-11-23 | US | |
| 201261656670 P | 2012-06-07 | US | |
| 201261722558 P | 2012-11-05 | US |
| (72) |
CHOWDHURY, Partha S., US
TICE, David, US
XIAO, Zhan, US
STEINER, Philipp, US
KINNEER, Krista, US
REBELATTO, Marlon, US
|
| (73) |
MedImmune, LLC,
One MedImmune Way, Gaithersburg, MD 20878,
US
|
| (54) | BINDING MOLECULES SPECIFIC FOR HER3 AND USES THEREOF |
| BINDING MOLECULES SPECIFIC FOR HER3 AND USES THEREOF |